In Vivo Targeting of Clostridioides Difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials

mBio - United States
doi 10.1128/mbio.00019-20
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

The Mechanisms of in Vivo Commensal Control of Clostridioides Difficile Virulence

2020English

Clostridioides Difficile Infection in the Asia-Pacific Region

Emerging Microbes and Infections
ImmunologyVirologyMicrobiologyEpidemiologyParasitologyMedicineDrug DiscoveryInfectious Diseases
2019English

Consortium of Probiotics Attenuates Colonization of Clostridioides Difficile

Frontiers in Microbiology
Microbiology
2019English

Management of Clostridioides Difficile Colitis: Insights for the Gastroenterologist

Therapeutic Advances in Gastroenterology
Gastroenterology
2019English

Genome Engineering of Clostridium Difficile Using the CRISPR-Cas9 System

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2018English

Clostridioides Difficile in National Food Surveillance, Slovenia, 2015 to 2017

Eurosurveillance
EnvironmentalVirologyPublic HealthEpidemiologyMedicineOccupational Health
2020English

Gut Microbiota Features Associated With Clostridioides Difficile Colonization in Puppies

PLoS ONE
Multidisciplinary
2019English

Factors and Conditions That Impact Electroporation of Clostridioides Difficile Strains

mSphere
MicrobiologyMolecular Biology
2020English

Clostridioides Difficile LuxS Mediates Inter-Bacterial Interactions Within Biofilms

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy